Injectable chitosan-hydroxyapatite hydrogels promote the osteogenic differentiation of mesenchymal stem cells by Ressler, Antonia et al.
 Document downloaded from: 
 
This paper must be cited as:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The final publication is available at 
 
 
Copyright 
 
Additional Information 
 
http://hdl.handle.net/10251/148015
Ressler, A.; Ródenas Rochina, J.; Ivankovic, M.; Ivankovic, H.; Rogina, A.; Ferrer, G. (2018).
Injectable chitosan-hydroxyapatite hydrogels promote the osteogenic differentiation of
mesenchymal stem cells. Carbohydrate Polymers. 197:469-477.
https://doi.org/10.1016/j.carbpol.2018.06.029
https://doi.org/10.1016/j.carbpol.2018.06.029
Elsevier
1 
 
Injectable chitosan-hydroxyapatite hydrogels promote the 1 
osteogenic differentiation of mesenchymal stem cells 2 
 3 
 4 
 5 
 6 
Antonia Ressler
a;*
, Joaquín Ródenas-Rochina
b, Marica Ivankovića, Hrvoje Ivankovića, Anamarija 7 
Rogina
a
, Gloria Gallego Ferrer
b,c 8 
 9 
a
 Faculty of Chemical Engineering and Technology, University of Zagreb, HR-10001 Zagreb, 10 
Marulićev trg 19, p.p.177, Croatia 11 
b
 Centre for Biomaterials and Tissue Engineering, Universitat Politècnica de València, Camino de 12 
Vera s/n, 46022 Valencia, Spain 13 
c
 Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine 14 
(CIBER-BBN), Valencia, Spain 15 
 16 
*Corresponding author: Antonia Ressler, Faculty of Chemical Engineering and Technology, 17 
University of Zagreb, HR-10001 Zagreb, Marulićev trg 19, p.p.177, Croatia, Tel: +385 01 4597 210, 18 
e-mail: aressler@fkit.hr 19 
 20 
E-mail addresses: aressler@fkit.hr (A. Ressler), jrodenasr@gmail.com (J. Ródenas Rochina), 21 
mivank@fkit.hr (M. Ivanković), hivan@fkit.hr (H. Ivanković), arogina@fkit.hr (A. Rogina), 22 
ggallego@ter.upv.es (G. Gallego Ferrer). 23 
 24 
 25 
 26 
 27 
*Manuscript
Click here to view linked References
2 
 
Abstract 28 
 Injectable hydrogels have emerged as promising biomaterials for tissue engineering 29 
applications. The goal of this study was to evaluate the potential of a pH-responsive chitosan-30 
hydroxyapatite hydrogel to be used as a three-dimensional support for encapsulated 31 
mesenchymal stem cells (MSCs) osteogenic differentiation. In vitro enzymatic degradation of 32 
the hydrogel, during 28 days of incubation, in simulated physiological condiditons, was 33 
characterized by swelling measurements, molecular weight determination and SEM analysis 34 
of hydrogel microstructure. Osteogenic differentiation of encapsulated MSCs was confirmed 35 
by osteogenic Runx2, collagen type I and osteocalcin immunostaining and alkaline 36 
phosphatase quantification. The deposition of late osteogenic markers (calcium phosphates) 37 
detected by Alizarin red and von Kossa staining indicated an extracellular matrix 38 
mineralization.  39 
 40 
 41 
 42 
 43 
 44 
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1. Introduction 50 
Over the past decade, injectable hydrogels have emerged as promising biomaterials for 51 
tissue engineering applications since they are generally biocompatible, biodegradable and can 52 
mimic the extracellular matrix (ECM) architecture. With the fast development of cell-based 53 
therapies, there is a growing need to develop injectable hydrogels as cell carriers, potentially 54 
avoiding an open surgery procedure and facilitating the use of minimally invasive approaches 55 
for material and cell delivery. The hydrogel precursor loaded with cells can be injected into 56 
the wound site, and experiences a sol–gel transition in situ due to physical or chemical 57 
stimuli.  58 
In the past years, many chitosan (Cht) based hydrogels have been developed for 59 
biomedical applications, as it is well documented and analyzed in review papers (Liu et al., 60 
2017; Racine, Texier & Auzély-Velty, 2017; Ta, Dass & Dunstan, 2008). A particular focus 61 
has been on chitosan hydrogels based on thermosensitive sol−gel transition initiated by 62 
glycerophosphate salt at body temperature, invented by Chenite et al. (Chenite, Buschmann, 63 
Wang, Chaput, & Kandani, 2001). The ability of chitosan-based hydrogels to support 64 
chondrogenic differentiation of human mesenchymal stem cells (hMSCs) has been confirmed 65 
(Cho et al., 2004; Dang et al., 2006). By combining chitosan–glycerophosphate with different 66 
concentrations of starch, a thermoresponsive hydrogel, that can be used as an injectable 67 
vehicle for cell delivery, has been prepared (Sa-Lima, Caridade, Mano, & Reis, 2010). 68 
Naderi-Meshkin et al. (Naderi-Meshkin et al., 2014) have developed a chitosan based 69 
injectable hydrogel via the combination of chitosan, glycerol phosphate, and hydroxyethyl 70 
cellulose. Systematic investigations of the viability, proliferation, and differentiation capacity 71 
of encapsulated mesenchymal stem cells in the hydrogel have indicated that the hydrogel has 72 
a high potential for cartilage tissue engineering. The study with human adipose-derived stem 73 
cells grown on chitosan hydrogel, cross-linked by 0.5% glutaraldehyde, (Debnath et al., 2015) 74 
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has revealed that chitosan hydrogel promotes cell proliferation coupled with > 90% cell 75 
viability.  76 
Chitosan hydrogels loaded with inorganic particles, such as hydroxyapatite (HAp), 77 
which is the inorganic component of bone and constitutes 60 % of native bone ECM, have 78 
been prepared to improve mechanical properties and bioactivity of hydrogels. The addition of 79 
hydroxyapatite phase into chitosan-based material has indicated better cell and protein 80 
adhesion, enhanced cell proliferation and higher osteogenic gene expression (Frohbergh et al., 81 
2012; Peter et al., 2010). Moreover, stem cell culture on chitosan-hydroxyapatite scaffolds 82 
modified by growth factors has been proposed as good strategy for bone tissue reconstruction 83 
(Liu et al., 2013). In a recent study (Demirtas, Irmak & Gümüşderelioğlu, 2017) a chitosan 84 
solution and its composite with nanostructured hydroxyapatite were mixed with cells and 85 
bioprinted successfully. It was observed that MC3T3-E1 pre-osteoblast cells within chitosan 86 
and chitosan-HA hydrogels had mineralized and differentiated osteogenically after 21 days of 87 
culture. It was proven that the presence of hydroxyapatite in chitosan hydrogels improved cell 88 
viability, proliferation and osteogenic differentiation. 89 
 90 
 In our recent study (Rogina et al., 2017b) a novel pH-responsive chitosan-91 
hydroxyapatite hydrogel, physically crosslinked with sodium bicarbonate, that allowed non-92 
cytotoxic fast gelation within 4 min, was prepared, with 30% (w/w) of HAp phase. The in situ 93 
synthesis of apatite phase has facilitated the physical crosslinking by reducing the acidity of 94 
the chitosan solution. Preliminary biological characterization of the hydrogel, performed by 95 
MTT test and live-dead assay, indicated good distribution and viability of encapsulated mouse 96 
embryonic fibroblasts and good resistance to shear. Based on these results we hypothesized 97 
that proposed injectable hydrogel could be a suitable osteoconductive cellular carrier.  98 
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 In this work, as a continuation of previous studies, in vitro enzymatic degradation of 99 
the hydrogel, during 28 days of incubation, in simulated physiological condiditons, has been 100 
analyzed. To evaluate the osteogenic potential of the hydrogel, an extensive biological 101 
characterization has been preformed as well, using porcine mesenchymal stem cells. Since our 102 
recent studies proved the osteogenic potential of highly porous composite Cht/HAp scaffold, 103 
with 30 wt% of in situ formed HAp, prepared by precipitation reaction and freeze-gelation 104 
method in static and dynamic cell culture conditions (Rogina et al., 2016; Rogina et al., 105 
2017a) in this work, we used the Cht/HAp scaffold, as a control. We hypothesized that the 106 
cellular response to chemically identical biomaterials may depend on the way the cells were 107 
incorporated in biomaterial. Therefore, two methods were applied: (1) MSCs were 108 
encapsulated during chitosan-hydroxyapatite hydrogel formation and (2) cells were seeded 109 
onto prefabricated porous chitosan-hydroxyapatite scaffold, and the results of biological 110 
characterization were compared.  111 
 112 
2. Materials and methods 113 
2.1. Materials 114 
 Chitosan (Cht, Mw = 100 – 300 kg/mol, deacetylation degree of 0.95 – 0.98, Acros 115 
Organics; sterilised with 96% of ethanol), calcium carbonate (CaCO3, calcite; TTT; sterilised 116 
by autoclave), urea phosphate ((NH2)2CO–H3PO4); Aldrich Chemistry; sterilised using 0.22 117 
µm filter), acetic acid (99.5 %, Sigma Aldrich; sterilised using 0.22 µm filter), sodium 118 
bicarbonate (NaHCO3, Gram-Mol; sterilised using 0.22 µm filter), sodium hydroxide (NaOH, 119 
Gram-Mol) and ethanol (EtOH, 96% Kefo) were all of analytical grade. Lysozyme (from hen 120 
egg white, ≥ 54 000 U/mg protein) in the form of powder was purchased from Sigma-Aldrich.  121 
 122 
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2.2. Synthesis of pH-responsive Cht/HAp hydrogel and scaffold 123 
 124 
 Based on our previous study (Rogina et al., 2015) chitosan-hydroxyapatite suspension 125 
was prepared by in situ wet precipitation method. Briefly, 1.2 wt% of chitosan (Cht) solution 126 
was prepared in 0.36 wt% acetic acid (HAc). Then, calcite (CaCO3) and urea phosphate 127 
((NH2)2CO–H3PO4) were added into Cht solution with Ca/P ratio of 1.67 to obtain 30 wt% of 128 
hydroxyapatite in final composite. This HAp content was selected based on our previous 129 
studies on chitosan composite scaffolds (Rogina et al., 2015; Rogina et al., 2016; Rogina et 130 
al., 2017a) where it resulted optimal in terms of mechanical and biological response as 131 
stimulates osteogenesis. 132 
The mixture was stirred 4 days at 50 °C. After 4 days of reaction, the Cht/HAp suspension 133 
was cooled down naturally to ambient temperature and used for preparation of pH-responsive 134 
hydrogel (1) and control material (2).  135 
(1) The pH-responsive, Cht/HAp system was prepared using 0.067 mg/L solution of sodium 136 
bicarbonate prepared in basal α-MEM (minimum essential medium), as described previously 137 
(Rogina et al., 2017b). After cooling down the Cht/HAp suspension and NaHCO3/α-MEM 138 
solution to 10 °C using ice bath, components were mixed together for 10 sec by stirring at 139 
1700 rpm. Homogenized suspension was then incubated at 37 °C to initiate physical 140 
crosslinking of Cht/HAp hydrogel.   141 
(2) The Cht/HAp scaffolds prepared by thermally induced phase separation and extraction 142 
(Rogina et al., 2015) were used as control materials. Briefly, Cht/HAp suspension was frozen 143 
over night at -22 °C and immersed in NaOH/EtOH (1:1 of volume portion) solution for 12 h 144 
at -22 °C. Then, samples were immersed in ethanol for 12 h at -22 °C and finally dehydrated 145 
in ethanol for 24 h, at ambient temperature.  146 
2.3.  In vitro enzymatic degradation 147 
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 The degradation behaviour of Cht/HAp crosslinked hydrogel was studied at two 148 
different concentrations of lysozyme (1.5 µg/mL corresponding to an activity of 82 U/mL and 149 
500 µg/mL corresponding to an activity of 27 300 U/mL) under static physiological 150 
conditions (phosphate buffer saline solution, PBS) on five replicas. Crosslinked hydrogels (n 151 
= 5, 500 μL) were incubated in 5 mL of PBS containing lysozyme at 37 °C during 28 days.  152 
Freshly prepared degradation medium was changed every third day to maintain the activity of 153 
lysozyme and to mimic physiological conditions in vivo (Porstmann et al., 1989). The 154 
Cht/HAp hydrogels were also incubated in phosphate buffer saline solution without 155 
containing lysozyme. At defined time points, the degradation medium was carefully removed 156 
in order to determine the weight of swollen hydrogel samples (Ws). Then, samples were 157 
lyophilised (Wd) and swelling ratio was calculated according to equation 1: 158 
 159 
   %  100s d
d
W W
Swelling ratio
W

          (1) 160 
 161 
The degradation of hydrogels was determined as the ratio of remaining hydrogel weight (Wd) 162 
and initial weight of the sample (Wd0) before enzymatic degradation (Eq. 2).  163 
 164 
 
0
    %    100d
d
W
Dry weight remaining ratio
W
        (2) 165 
 166 
The influence of degradation medium on hydrogels’ microstructure was analysed by scanning 167 
electron microscopy (SEM). Dried degraded samples were coated with plasma of gold and 168 
palladium for 90 s. The microscopic imaging was carried out by the electron microscope 169 
TESCAN Vega3SEM Easyprobe at electron beam energy of 15 keV.  170 
 171 
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2.4. Gel permeation chromatography 172 
 The distribution of molecular weight of Cht/HAp hydrogels during enzymatic 173 
degradation was analysed by Gel Permeation Chromatography (GPC), at 35 °C, with a Waters 174 
Breeze GPC system and a 1525 Binary HPLC pump (Waters Corporation, Milford, MA) 175 
equipped with a 2414 refractive index detector and four serial columns of water 176 
(Ultrahydrogel 7.8 mm ID X 30 cm). The degraded hydrogel samples were dissolved in acetic 177 
buffer (CH3COOH 0.5 M/CH3COONa 0.2 M, pH = 4.5) used as a mobile phase at a flow rate 178 
of 0.5 mL/min and 20 µL injection volume, as previously described by Gámiz-González et al. 179 
(Gámiz-González et al., 2015). 180 
 181 
2.5. Cell encapsulation/seeding 182 
Porcine mesenchymal stem cells from bone marrow were obtained, using a modified protocol 183 
for human MSCs isolation (Gamiz-Gonzalez et al., 2017; Lennon & Caplan, 2006; Rodenas-184 
Rochina, Kelly, Ribelles & Lebourg, 2016; Thorpe et al., 2008). For expansion, the cells were 185 
seeded at 4 × 10
5
 cells/cm
2
 in a T75 cm
2 culture flask with high glucose Dulbecco’s modified 186 
Eagle’s medium (DMEM), enriched with 10% of FBS, 2% penicillin/streptomycin and 125 187 
µg/mL amphotericin B until passage 1. From passage 1 to 3 culture media was supplemented 188 
with 5 ng/mL recombinant human fibroblast growth factor‐ 2 and without amphotericin B. 189 
Cells at passage 3 were used for tri-potentiality assessment (Thorpe et al., 2008) and cell 190 
culture seeding. 191 
For cell encapsulation, the cells were resuspended at a density of 1.4 × 10
6
 cells/mL in a 192 
Cht/HAp/NaHCO3 solution, with pH of 7.01 and at 10 ºC suitable for cell survival, as 193 
described in our previous study (Rogina, et al.; 2017b). 194 
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The cell/hydrogel system was quickly seeded on 24-well plates, 200 µL per well, and 195 
incubated in humidified atmosphere at 37 °C and 5% of CO2 for 4 min to induce physical 196 
crosslinking. Then, samples were incubated with 2 mL of DMEM medium supplemented with 197 
10% of FBS (fetal bovine serum) and 1% of penicillin/streptomycin in a humidified 198 
atmosphere with 5% CO2 at 37 °C for 24 h. After 24 h, basal medium was changed with 199 
DMEM supplemented with 10% of FBS, 1% of penicillin/streptomycin, 50 µg/mL of ascorbic 200 
acid, 10 mmol/L of β-glycerophosphate and 1 µmol/L of dexamethasone. The medium was 201 
refreshed every third day.  202 
As a control material, Cht/HAp scaffolds were cut into cylindrical shape pieces of 7 mm 203 
diameter and 1-2 mm height, sterilized in 96% ethanol and conserved at 4 °C for 24 h. After 204 
sterilization, scaffolds were washed 3 times with Dulbeccoʼs modified Eagleʼs culture 205 
medium (DMEM), left in DMEM for 24 h and transported into 24-well plate. Scaffolds were 206 
seeded with the same cell density as hydrogels, according to the volume of the scaffold. The 207 
cells suspension was put on top of the scaffold and incubated for 15 min to allow cells 208 
attachment and migration inside the scaffold. Then cell culture media was added in the same 209 
way as for the hydrogels. 210 
 211 
2.6. Cell Counting 212 
 Cell proliferation into Cht/HAp hydrogels and control materials was examined at 1, 7 213 
and 14 days of culture. After cutting three 50 μm slices, of five different replicas, samples 214 
were stained with DAPI. Images were taken by confocal fluorescence microscope (Zeiss LSM 215 
780, Axio Observer) in 16-tile mode scanning and the cell nuclei were counted. Average 216 
number of cells at different time points is expressed as average value corrected by standard 217 
error of the mean (SEM).  218 
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 219 
2.7. Alkaline phosphatase analysis 220 
 The activity of alkaline phosphatase (ALP) was measured as the conversion of p-221 
nitrophenylphosphate to p-nitrophenol as the result of the cellular extract activity, using 222 
SensoLyte® pNPP Alkaline Phosphatase Assay kit *Colorimetric* (AnaSpec) according to 223 
the manufacturer instructions. Samples were gathered at 7 and 14 days. For each time point, 224 
three acellular samples were used as blanks. After washing the samples with Dulbecco's 225 
phosphate buffered saline (DPBS) and lysis buffer (DPBS 1X with 0.2 % Triton X-100) 226 
solution, 200 µL of lysis buffer was added and homogenized with hydrogel. All samples were 227 
incubated in ice bath and centrifuged at 4 °C for 7 min to precipitate cellular and material 228 
debris. Then, 50 µL of each standard and sample with 50 µL of p-nitrophenylphosphate were 229 
placed in 96-well plate in triplicates. The plate was incubated in the dark for 40 min at room 230 
temperature. Absorbance was measured at 405 nm using Perkin-Elmer VICTOR3 multi-plate 231 
reader. The concentration of the ALP was determined using a standard curve. 232 
2.8. Immunofluorescent imaging of cell markers 233 
 Differentiation of MSCs at 7 and 14 days was evaluated by different antibodies to 234 
confirm the expression of differentiation markers: runt-related transcription factor 2 (Runx2), 235 
collagen type I (COLL I) and osteocalcin (OCN). Cultured samples were fixed in 4% of 236 
formaldehyde at 4 °C for 1 h and washed with DPBS. Sample slices of Cht/HAp hydrogels 237 
with 50 μm of thickness were permeabilized with DPBS/0.5% Triton X-100 for 5 min at room 238 
temperature, further treated with 1% of sodium dodecyl sulfate (SDS) in DPBS for 5 minutes 239 
to perform the antigen retrieval, and subsequently washed with DPBS. Then, samples were 240 
blocked by DPBS/1% bovine serum albumin (BSA)/10% goat serum for 30 min. Incubation 241 
with primary antibodies, with dilution 1:50 (Runx2), 1:100, (COLL I) and 1:200 (OCN) in 242 
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DPBS/ 1% bovine serum BSA /10% goat serum, was performed for 5 h at room temperature. 243 
Further, samples were washed with DPBS/0.05% Tween 20 surfactant and incubated with 244 
Bodipy FL Dye (Fisher) dilution 1:400 to stain the cytoskeleton and secondary antibody anti-245 
mouse conjugated with alexa 555 for 1 h at room temperature. Incubation with secondary 246 
antibodies was not performed for Runx2, because primary antibody is labelled FITC. Finally, 247 
samples were mounted with Vectashield DAPI for nuclei staining. Detection of protein 248 
markers was performed by confocal fluorescence microscope (Zeiss LSM 780, Axio 249 
Observer). 250 
The staining antibodies on control materials were performed on whole sample. After washing 251 
second antibodies, control materials were fixed and included in cryoprotective medium at -80 252 
°C. Then, samples were cut into slices with 50 μm of thickness and mounted with Vectashield 253 
DAPI.  254 
2.9. Histological Analysis 255 
 Cultured samples were fixed with formaldehyde, included in optimum cutting 256 
temperature compound (OCT), frozen at -80 °C and cut into slices with 17 μm of thickness. 257 
Detection of phosphate deposits on Cht/HAp hydrogels were determined using von Kossa 258 
staining. Samples were washed with distilled water and incubated in a 5% AgNO3 solution 259 
(Sigma-Aldrich) under ultraviolet light for 20 min. Further, samples were washed with 260 
distilled water and 2% Na2S2O3 (Sigma-Aldrich) to remove unreacted AgNO3. Finally, the 261 
cells were stained using a neutral red solution (Sigma-Aldrich) for 2 minutes. Detection of 262 
calcium deposits was determined using Alizarin red S staining. Samples were incubated with 263 
2% of alizarin red solution (pH of 4.2; Sigma-Aldrich) for 4 minutes. After staining, samples 264 
were washed with distilled water and mounted with 80% of glycerol solution (Sigma-265 
Aldrich). 266 
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2.10. Statistical analysis 267 
 All experiments were performed in triplicates or more. Statistical comparison between 268 
two groups was tested using one-way ANOVA test with value p < 0.05 and p < 0.01 269 
considered statistically significant. 270 
 271 
3. Results 272 
3.1. In vitro degradation testing 273 
 In the present study, enzymatic degradation of Cht/HAp hydrogel was studied at 37 °C 274 
as a function of time, for 28 days, by monitoring swelling behaviour, dry weight loss, 275 
molecular weight (Mw) and polydispersity index (PDI). To distinguish between enzymatic 276 
degradation and dissolution, Cht/HAp hydrogels were exposed to phosphate buffer solution 277 
(PBS) without and with (1.5 and 500 µg/mL) lysozyme, as used in reported studies (Jin et al., 278 
2009; Moura, Faneca, Lima, Gil & Figueiredo, 2011; Yang et al., 2010). The lysozyme 279 
concentration of 500 μg/mL better mimics the in vivo physiological conditions, as the 280 
lysozyme level in the extracellular matrix of human tissues can increase up to 1,000- fold 281 
(Hou et al., 2012) the amount usually found in serum (0.95~2.45 μg/mL) (Jin et al., 2009; 282 
Park, Choi & Lee, 2013;). 283 
The results shown in Fig. 1a suggest an increase in swelling ratio with incubation time for all 284 
investigated systems. However, there is no significant difference in swelling ratios among 3, 285 
14 and 28 days for Cht/HAp hydrogels (Fig. 1a) incubated in non-enzymatic conditions 286 
(Cht/HAp_PBS) and in 1.5 µg/mL of lysozyme solution (Cht/HAp_1.5 µg/mL). For Cht/HAp 287 
hydrogel incubated in the 500 µg/mL of lysozyme solution (Cht/HAp_500µg/mL) there is a 288 
significant difference between swelling ratios between 3 and 28 days. As seen from Figure 1b 289 
the weight loss of Cht/HAp hydrogel in different incubation media follows the decreasing 290 
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trend: PBS < 1.5 µg/mL of lysozyme solution < 500 µg/mL of lysozyme solution. However, 291 
there is no significant difference in dry weight remaining ratio among 3, 14 and 28 days. 292 
Weight average molecular weight (Mw) reduction during incubation was observed in all 293 
investigated systems (Fig. 1c), and the degradation is the most pronounced in 500 µg/mL of 294 
lysozyme solution. Initial molecular weight, Mw0 ≈ 222 000, decreased after 3 and 28 days, in 295 
non-enzymatic condition to 170 000 and 113 000, respectively, in 1.5 µg/mL of lysozyme 296 
solution to 123 000 and 79 000, respectively, and in 500 µg/mL of lysozyme solution to 48 297 
000 and 36 500, respectively. Polydispersity index stayed around 2 throughout all degradation 298 
process which could indicate a random depolymerisation (Holme, Davidsen, Kristiansen & 299 
Smidsrød, 2008). 300 
In all investigated systems the decrease in molecular weight is accompanied by an increase of 301 
the swelling ratio, but only in system Cht/HAp_500µg/mL a significant difference in swelling 302 
ratio between 3 and 28 days was observed. It is expected that shorter chitosan chains in 303 
Cht/HAp_500µg/mL, show smaller extent of chain entanglements and physical crosslinking 304 
density, compared to other two investigated systems, resulting in higher swelling ratios. To 305 
provide a better understanding of the correlation between chitosan molecular weight and 306 
swelling ratio other molecular parameters that describe the network structure of hydrogels 307 
should be determined, such as the critical entanglement molecular weight and the average 308 
molecular weight between crosslinks. (i.e., mesh size). 309 
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 310 
Fig. 1. Swelling ratio (a); dry weight remaining ratio (b); and weight average molecular 311 
weight (c) of Cht/HAp hydrogel incubated in different degradation media at 37 °C as a 312 
function of time. Significant difference between two groups: *(p < 0.05), ** (p < 0.01). 313 
 The microstructures of the cross section of Cht/HAp_PBS and Cht/HAp_1.5 µg/mL 314 
hydrogels shown in Fig. 2b confirm larger pores after 3 days of incubation at 37 °C compared 315 
to initial Cht/HAp hydrogel (0 day), as a result of water absorption. The pore structure of 316 
Cht/HAp_500µg/mL hydrogel is fully disrupted after 3 days of incubation as a result of high 317 
degradation rate. However, it retained the porous structure which is important for the 318 
diffusion of nutrients, metabolic waste products, and oxygen. In this study, deacetylation 319 
degree of chitosan is in the range 0.95 – 0.98 and a high stability under enzymatic conditions 320 
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was expected (Freier, Koh, Kazazian & Shoichet, 2005). After 28 days of incubation highly 321 
porous structure was maintained in all degradation conditions indicating a stable Cht/HAp 322 
hydrogel. SEM micrographs of Cht/HAp hydrogels cross section confirmed uniform 323 
degradation through entire volume of hydrogel and good particles distribution of in situ 324 
precipitated HAp within chitosan matrix (see Fig. 2a). In comparison to the hydrogel prepared 325 
by mixing previously prepared hydroxyapatite particles within chitosan/β-glycerophosphate 326 
(Chen et al., 2016) in situ precipitation performed in this work results in smaller particles size. 327 
 328 
 329 
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Fig. 2. SEM micrographs of dried hydrogel with in situ precipitated HAp particles within 330 
chitosan matrix (a) and Cht/HAp hydrogel incubated for 3 and 28 days under different 331 
degradation conditions (b).  332 
3.2. Biological characterization 333 
 As described in experimental section, for both, the hydrogel and the scaffold, the cell 334 
counting was performed by imaging three DAPI stained 50 μm slices, of five different 335 
replicas. Images were taken by confocal fluorescence microscope in 16-tile mode scanning. 336 
Fig 3a represents the average cell number of the total 16 tiles at 3 different slices. It is 337 
noteworthy that counted cell number does not represent total cell number, but average number 338 
of cells on material slices imaged in 16-tile mode.  339 
As shown in Fig. 3a, lower cell number on scaffold at day 0, compared to hydrogel was 340 
observed, although, the same number of cells were encapsulated in the hydrogel and seeded 341 
on the scaffold. It could indicate that all cells did not succeed to achieve a stable adhesion and 342 
could easily detach from the scaffold. An increase in the number of cells after 7 days of 343 
culture was obtained in both Cht/HAp hydrogel and the control, indicating that new injectable 344 
Cht/HAp hydrogel is suitable for cell encapsulation and proliferation and can be used as a cell 345 
carrier for bone tissue engineering. After an initial increase in cell number, there is not a 346 
significant difference in the average cell number between 7 and 14 days. This could indicate 347 
that cells stopped proliferating and probably started to differentiate, what was confirmed by 348 
the presence of osteogenic markers, as will be shown below. Figure S1 of Supplementary 349 
material confirms that cells stayed homogeneously dispersed inside hydrogel during 14 days 350 
of cell culture indicating that the microstructure and physically crosslinked chitosan chains do 351 
not allow cell to migrate outside the hydrogel. 352 
 353 
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 Cells secrete alkaline phosphatase, a characteristic parameter of osteoblasts. Although 354 
there is no significant difference in ALP concentration (Fig. 3b) between 7 and 14 days of cell 355 
culture in the Cht/HAp hydrogel, it seems that the tendency is to increase with the culture 356 
time. A clear significant increase of ALP secretion was measured in the control scaffolds.  357 
 358 
Fig. 3. The cell number (a) and alkaline phosphatase activity (ALP) (b) of MSCs encapsulated 359 
in Cht/HAp hydrogel and control after 7 and 14 days of cell culture. Significant difference 360 
between two groups (p <0.05) is designated with (*). 361 
 Along with ALP activity quantification, osteogenic differentiation of MSC cells 362 
encapsulated in Cht/HAp hydrogel was determined by analysing the expression of runt-related 363 
transcription factor 2 (Runx2), collagen I (COLL I) and osteocalcin (OCN) at 7 and 14 days 364 
of cell culture. Images obtained by confocal fluorescence microscopy are shown in Fig. 4a-c. 365 
Cell nuclei stained with DAPI appeared in blue, while Runx2 (Fig. 4a) appeared in green, 366 
COLL I (Fig. 4b) and OCN (Fig. 4c) appeared in red and cytoskeleton (actin) in green. 367 
Unfortunately, the quality of immunofluorescence images is poor due to strong auto-368 
fluorescence of hydrogel/scaffold. To minimize the sample interference the images were 369 
processed by ImageJ software, which resulted in darkening of the final image. To compensate 370 
this we completed the study with additional colorimetric stains (alizarin red and von Kossa) as 371 
will be shown later.  372 
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Previous in vitro studies (Komori, 2003) demonstrated that Runx2 can enhance the expression 373 
of bone matrix genes like collagen type I, osteopontin, osteocalcin, bone sialoprotein (BSP) 374 
and fibronectin. According to that, expression of COLL I and OCN was expected and found at 375 
7 and 14 days of cell culture, implying good osteogenic potential of prepared Cht/HAp 376 
hydrogel. The round shape morphology of MSCs is evident after 7 and 14 days of cell culture, 377 
which is consistent with the literature (Wang, Rao & Stegemann, 2013; Caliari, Vega, Kwon, 378 
Soulas & Burdick, 2016). 379 
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 380 
Fig. 4. The expression of Runx2 (a), collagen type I (COLL I) (b) and osteocalcin (OCN) (c) 381 
encapsulated in Cht/HAp hydrogels after 7 and 14 days of cell culture. Cell nucleus stained 382 
with Dapi (blue fluorescence), Runx2 (green fluorescence) (a). Actin cytoskeleton stained 383 
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with phallacidin (green fluorescence), COLL I and OCN (red fluorescence) (b and c). Scale 384 
bar: 50 µm. 385 
 Mineralized ECM in the Cht/HAp hydrogels was identified by von Kossa and Alizarin 386 
red staining (Fig. 5), where calcium deposits are positively stained in red and phosphate 387 
deposits in brown or black. After 7 and 14 days of culture higher intensity of red and brown 388 
(black) deposits indicate that mineralization of ECM occurred. Obtained results of 389 
differentiated cells after 7 and 14 days of cell culture were compared with Cht/HAp hydrogel 390 
with undifferentiated cells at day 0 (Ctrl in Fig. 5).  391 
 392 
Fig. 5. Positive staining for calcium deposits after 7 and 14 days of culture is observable by 393 
red colour determined using alizarin red S assay. Positive staining for phosphate deposits after 394 
7 and 14 days is observable by brown and black colour determined using von Kossa assay. 395 
Cht/HAp hydrogel with undifferentiated cells was used to indicate the material/cell 396 
interference (Ctrl). Scale bar: 100 µm. 397 
4. Discussion 398 
21 
 
 In our previous study (Rogina et al., 2017b) an injectable, pH-responsible, physically 399 
crosslinked hydrogel based on chitosan and in situ formed hydroxyapatite, with 30% (w/w) of 400 
HAp phase, was prepared. The viscoelastic behaviour of hydrogel was observed in the range 401 
of strain deformation up to approximately 10%. The G"/Gˈ ratio of 0.04 and linear 402 
viscoelasticity above 5% of strain deformation, indicated that chitosan/HAp hydrogel could 403 
behave as a strong physical gel. Compared to the storage modulus of similar physically 404 
crosslinked chitosan-based system, with 30% (w/w) of bioglass nanoparticles, and β-405 
glycerophosphate as a gelling agent (Couto, Hong & Mano, 2009) our gel showed 1.5-fold 406 
higher storage modulus, indicating better resistance to shear. Distribution and viability of 407 
encapsulated mouse embryonic fibroblasts within the hydrogel up to 7 days of culture was 408 
confirmed by live dead staining. 409 
As a continuation of previous study, in this work an extensive in vitro characterization of the 410 
hydrogel, using porcine MSCs, was performed, including, in vitro enzymatic degradation 411 
during 28 days of incubation, in simulated physiological condiditons. It was hypothesized that 412 
in situ synthesis of hydroxyapatite within chitosan matrix would provide a homogeneous 413 
dispersion of hydroxyapatite particles with positive influence on osteoinduction and 414 
differentiation of MSCs that can lead to homogeneous bone regeneration.  415 
 Swelling behaviour, structural integrity and rate of degradation are critical variables in 416 
hydrogel design that affect the rate of tissue formation. Hydrogels derived from natural 417 
polymers often are not stable at physiological conditions and undergo rapid degradation (Tan 418 
& Marra, 2010). As cell carriers, hydrogels stability during cell encapsulation and 419 
differentiation at physiological conditions is required. Chitosan has the ability to readily swell 420 
up when exposed in a biological environment. Degradation of chitosan takes place via 421 
hydrolysis, as interactions with water molecules break the polymeric network into smaller 422 
chains whereby the -1-4 N-acetyl glucosamine units of Cht undergo chain scission mainly by 423 
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lysozymes present in the body. This phenomenon leads to release of amino sugars, which can 424 
be incorporated into metabolic pathways or excreted through the body (Liu, Zhou & Sun, 425 
2012; Qasim et al., 2017; Ren, Yi, Wang & Ma, 2005; Tomihata & Ikada, 1997). Other by 426 
products of Cht degradation include saccharides which become part of the normal metabolic 427 
process (Kumar, Muzzarelli, Muzzarelli, Sashiwa & Domb, 2004). 428 
The results obtained in this work show that new physically crosslinked Cht/HAp hydrogel is 429 
highly stable during 28 days, even in extreme conditions with much higher concentration of 430 
lysozyme than physiological, which is important for the eventual future clinical application of 431 
the material. The weight loss after 28 days of incubation is comparable to the literature data 432 
reported for chemically crosslinked hydrogels based on chitosan, showing 30 – 70 % weight 433 
loss after 28 days of incubation under enzymatic physiological conditions, depending on 434 
crosslinking degree (Moura et al., 2011; Xu et al., 2016). The big advantage of the synthesis 435 
applied in present work is simple chitosan gel formation, feasible under mild conditions, 436 
without using toxic cross-linking agents. The cross-sectional SEM images of the freeze-dried 437 
hydrogels (Fig. 2) demonstrate a porous and netlike structure and good particles distribution 438 
of in situ precipitated HAp within chitosan matrix. The porous structures provide an 439 
environment suitable for the attachment, growth, and differentiation of MSCs, and transport 440 
of nutrients to the cells. 441 
Many in vitro and in vivo studies have suggested that MSCs have the potential to enhance 442 
osteogenesis while being delivered in critical sized bone defects with ability to migrate to 443 
defect sites. Despite MSCs capacity to differentiate to osteoblasts, MSCs ability to support a 444 
regenerative microenvironment is of great importance. MSCs can differentiate to multiple cell 445 
types like chondrocytes, osteoblasts and adipocytes (Oryan, Kamali, Moshiri & Baghaban 446 
Eslaminejad, 2017). MSCs were encapsulated in an injectable thermosensitive chitosan-447 
glycerophosphate where differentiation occurred to chondrocytes (Richardson, Hughes, Hunt, 448 
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Freemont & Hoyland, 2008). The same tendency was observed in other chitosan based 449 
hydrogels (Cho et al., 2004; Jin, 2009; Hu, 2012). Wang and Stegemann (Wang & 450 
Stegemann, 2010) used β-glycerophosphate as gelling agent to obtain physically crosslinked 451 
chitosan hydrogel. High concentration of β-glycerophosphate was required to obtain gelation 452 
time below 10 min. Additionally, DNA content of encapsulated human bone marrow 453 
mesenchymal stem cells decreased over time suggesting that cells were dying in chitosan 454 
hydrogel. Incorporation of previously prepared HAp particles into chitosan/gelatin scaffold 455 
enhanced osteogenic differentiation (Zhao, Grayson, Ma, Bunnell & Lu, 2006). In the present 456 
work the differentiation of MSCs encapsulated in the Cht/HAp hydrogel was evaluated after 7 457 
and 14 days of cell culture. Colorimetric quantification of alkaline phosphatase activity and 458 
immunofluorescent imaging was used to detect the expression of osteogenic markers.  459 
Detection of Runx2 as a principal osteogenic master gene for bone formation as well as 460 
COLL I and OCN, characteristic genes of differentiation process, indicates good osteogenic 461 
signal of Cht/HAp hydrogel where MSCs differentiated into an osteoblast phenotype 462 
indicating possible application of Cht/HAp hydrogel as cell carrier for bone tissue 463 
engineering.  464 
Osteogenesis depends on the material’s composition, surface properties, charge and 465 
wettability, but also on the material stiffness. Literature reports that stiffness of about 1,5 kPa 466 
upregulated osteogenic expression whereas softer matrices are not so osteogenic (Murphy, 467 
Matsiko, Haugh, Gleeson & O’Brien, 2012). That is the possible reason why the injectable 468 
Cht/HAp hydrogel that possess a lower modulus, around 100 Pa (Rogina et.al. 2017b) than 469 
the Cht/HAp scaffold has a lower ALP activity compared to the scaffold. 470 
The deposition of late osteogenic markers (calcium phosphates) detected by Alizarin red and 471 
Von Kossa staining indicated an extracellular matrix (ECM) mineralization. It can be 472 
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concluded that Cht/HAp hydrogel provide suitable environment for enhanced osteogenesis of 473 
MSCs. Further in vivo studies on animal model need to be performed to examine 474 
biodegradation and osteogenesis to confirm the applicability of Cht/HAp hydrogel for bone 475 
tissue engineering. 476 
5. Conclusion 477 
 Present research has shown that novel chitosan/hydroxyapatite physically crosslinked 478 
hydrogel act as the three-dimensional support for MSCs proliferation and differentiation into 479 
osteoblast cells. The expression of characteristic bone genes, Runx2, ALP, COLL I, OCN and 480 
calcium phosphate deposits, indicated that ECM mineralisation took place during 14 days of 481 
cell culture. MSCs are homogeneously dispersed through entire Cht/HAp hydrogel during cell 482 
culture, which is crucial for full bone healing. Prepared Cht/HAp hydrogel is highly stable 483 
under physiological and enzymatic conditions supporting the osteogenesis of encapsulated 484 
mesenchymal stem cells.  485 
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